AVT06, a promising biosimilar to aflibercept (Eylea), shows comparable efficacy and safety for treating neovascular age-related macular degeneration (AMD), enhancing patient access.

Researchers hope to replicate larger blood vessels like arteries and veins and potentially have real blood circulating ...

Combining Tissue Valve Replacement with Total Arterial Bypass (CABG) offers safer, more durable heart surgery outcomes by ...

The following checklist can be used to assist you in comparing assisted living communities. Ideally, both caregiver and care recipient will be involved in the selection process. If so, it ...

CIC biomaGUNE researchers use 3D bioprinting to produce artificial blood vessels - offering new ways to study diseases and ...